These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 18483203)

  • 1. APRIL facilitates viral-induced erythroleukemia but is dispensable for T cell immunity and lymphomagenesis.
    Hardenberg G; Fernandez L; Hendriks J; Chebli K; Jacquet C; Sitbon M; Hahne M; Medema JP
    J Leukoc Biol; 2008 Aug; 84(2):380-8. PubMed ID: 18483203
    [TBL] [Abstract][Full Text] [Related]  

  • 2. APRIL modulates B and T cell immunity.
    Stein JV; López-Fraga M; Elustondo FA; Carvalho-Pinto CE; Rodríguez D; Gómez-Caro R; De Jong J; Martínez-A C; Medema JP; Hahne M
    J Clin Invest; 2002 Jun; 109(12):1587-98. PubMed ID: 12070306
    [TBL] [Abstract][Full Text] [Related]  

  • 3. APRIL affects antibody responses and early leukocyte infiltration, but not influenza A viral control.
    Hardenberg G; van der Sluijs K; van der Poll T; Medema JP
    Mol Immunol; 2008 Jun; 45(11):3050-8. PubMed ID: 18471884
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deregulated expression of RasGRP1 initiates thymic lymphomagenesis independently of T-cell receptors.
    Klinger MB; Guilbault B; Goulding RE; Kay RJ
    Oncogene; 2005 Apr; 24(16):2695-704. PubMed ID: 15829980
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytotoxic T lymphocyte recognition of gp70 on Friend virus-induced erythroleukemia cell clones.
    Collins JK; Britt WJ; Chesebro B
    J Immunol; 1980 Sep; 125(3):1318-24. PubMed ID: 6967898
    [No Abstract]   [Full Text] [Related]  

  • 6. Germ line insertions of moloney murine leukemia virus in the TLL mouse causes site-specific differences in lymphoma/leukemia frequency and tumor immunophenotype.
    Johansson AS; Eriksson M; Norén-Nyström U; Larefalk A; Eriksson B; Holmberg D
    Anticancer Res; 2006; 26(4B):2873-8. PubMed ID: 16886607
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LFA-1 decreases the antigen dose for T cell activation in vivo.
    Wang Y; Shibuya K; Yamashita Y; Shirakawa J; Shibata K; Kai H; Yokosuka T; Saito T; Honda S; Tahara-Hanaoka S; Shibuya A
    Int Immunol; 2008 Sep; 20(9):1119-27. PubMed ID: 18644832
    [TBL] [Abstract][Full Text] [Related]  

  • 8. T cell-mediated immunity to oncornavirus-induced tumors. II. Ability of different T cell sets to prevent tumor growth in vivo.
    Leclerc JC; Cantor H
    J Immunol; 1980 Feb; 124(2):851-4. PubMed ID: 6243333
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Active CD4+ helper T cells directly stimulate CD8+ cytotoxic T lymphocyte responses in wild-type and MHC II gene knockout C57BL/6 mice and transgenic RIP-mOVA mice expressing islet beta-cell ovalbumin antigen leading to diabetes.
    Ye Z; Ahmed KA; Hao S; Zhang X; Xie Y; Munegowda MA; Meng Q; Chibbar R; Xiang J
    Autoimmunity; 2008 Nov; 41(7):501-11. PubMed ID: 18855194
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In situ detection of virus- and tumor-specific T-cell immunity.
    Haanen JB; van Oijen MG; Tirion F; Oomen LC; Kruisbeek AM; Vyth-Dreese FA; Schumacher TN
    Nat Med; 2000 Sep; 6(9):1056-60. PubMed ID: 10973329
    [No Abstract]   [Full Text] [Related]  

  • 11. Spontaneous regression of Friend murine leukemia virus-induced erythroleukemia. V. Cell-mediated antivirus immunity in mice undergoing erythroleukemia regression and in leukemic mice.
    Johnson CS; Fouchey SP; Furmanski P
    J Natl Cancer Inst; 1980 Mar; 64(3):645-53. PubMed ID: 6965511
    [No Abstract]   [Full Text] [Related]  

  • 12. Structural determinants of T-cell receptor bias in immunity.
    Turner SJ; Doherty PC; McCluskey J; Rossjohn J
    Nat Rev Immunol; 2006 Dec; 6(12):883-94. PubMed ID: 17110956
    [TBL] [Abstract][Full Text] [Related]  

  • 13. "APRIL hath put a spring of youth in everything": Relevance of APRIL for survival.
    Kimberley FC; Hahne M; Medema JP
    J Cell Physiol; 2009 Jan; 218(1):1-8. PubMed ID: 18726990
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IL-15 is critical for the maintenance and innate functions of self-specific CD8(+) T cells.
    Itsumi M; Yoshikai Y; Yamada H
    Eur J Immunol; 2009 Jul; 39(7):1784-93. PubMed ID: 19544306
    [TBL] [Abstract][Full Text] [Related]  

  • 15. APRIL promotes B-1 cell-associated neoplasm.
    Planelles L; Carvalho-Pinto CE; Hardenberg G; Smaniotto S; Savino W; Gómez-Caro R; Alvarez-Mon M; de Jong J; Eldering E; Martínez-A C; Medema JP; Hahne M
    Cancer Cell; 2004 Oct; 6(4):399-408. PubMed ID: 15488762
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blocking the APRIL circuit enhances acute myeloid leukemia cell chemosensitivity.
    Bonci D; Musumeci M; Coppola V; Addario A; Conticello C; Hahne M; Gulisano M; Grignani F; De Maria R
    Haematologica; 2008 Dec; 93(12):1899-902. PubMed ID: 18838478
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased antigen cross-presentation but impaired cross-priming after activation of peroxisome proliferator-activated receptor gamma is mediated by up-regulation of B7H1.
    Klotz L; Hucke S; Thimm D; Classen S; Gaarz A; Schultze J; Edenhofer F; Kurts C; Klockgether T; Limmer A; Knolle P; Burgdorf S
    J Immunol; 2009 Jul; 183(1):129-36. PubMed ID: 19535643
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The duration of TCR/pMHC interactions regulates CTL effector function and tumor-killing capacity.
    Riquelme E; Carreño LJ; González PA; Kalergis AM
    Eur J Immunol; 2009 Aug; 39(8):2259-69. PubMed ID: 19637198
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antigen-specific CD4+ effector T cells: analysis of factors regulating clonal expansion and cytokine production: clonal expansion and cytokine production by CD4+ effector T cells.
    Ohnuki K; Watanabe Y; Takahashi Y; Kobayashi S; Watanabe S; Ogawa S; Kotani M; Kozono H; Tanabe K; Abe R
    Biochem Biophys Res Commun; 2009 Mar; 380(4):742-7. PubMed ID: 19338745
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of an immediate splenic precursor of CD8+ dendritic cells capable of inducing antiviral T cell responses.
    Bedoui S; Prato S; Mintern J; Gebhardt T; Zhan Y; Lew AM; Heath WR; Villadangos JA; Segura E
    J Immunol; 2009 Apr; 182(7):4200-7. PubMed ID: 19299718
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.